【摘要】 目的 評價α2受體激動劑是否可以降低七氟烷引起的小兒術后躁動的發生率。 方法 通過檢索Medline、荷蘭醫學文摘、Cochrane臨床試驗數據庫、中國生物醫學文獻數據庫和中國期刊網全文數據庫等數據庫，收集可樂定或右美托咪啶對七氟烷引起的小兒術后躁動的預防作用的隨機對照試驗（randomized controlled trial，RCT），提取資料和評估方法學質量，采用Cochrane協作網RevMan 5.0軟件進行Meta分析。 結果 最終納入11個RCT，其中104例患兒預防性使用右美托咪啶，268例患兒使用可樂定，365例患兒使用安慰劑。Meta分析顯示，可樂定組小兒術后躁動發生率的比值比（OR）為0.31，95%CI為（0.15，0.61）（P=0.000 8）；右美托咪啶組小兒術后躁動發生率的OR為0.16，95%CI為（0.08，0.31）（Plt;0.000 01）。 結論 α2受體激動劑可以顯著降低七氟烷引起的小兒術后躁動的發生率。【Abstract】 Objective To determine whether alpha2-adrenoceptor agonists can decrease emergence agitation (EA) in pediatric patients after sevoflurane anesthesia. Methods The Medline, Embase, Cochrane Library, CBM and CNKI were searched. All randomized controlled trials comparing clonidine or dexmedetomidine with other interventions in preventing emergence agitation after sevoflurane anesthesia were retrieved. Study selection and assessment, data collection and analyses were undertaken. Meta-analysis was done using the Cochrane Collaboration RevMan 5.0 software. Results Eleven articles reached our inclusion criteria and were included in the Meta-analysis. A total of 104 children treated with dexmedetomidine, 268 children treated with clonidine, and 365 children treated with placebo were evaluated for the incidence of emergence agitation. The pooled odds ratio for the clonidine subgroup was 0.31, with a 95% confidence interval of 0.15-0.61 (P=0.000 8). The pooled odds ratio for the dexmedetomidine subgroup was 0.16, with a 95% confidence interval of 0.08-0.31 (Plt;0.000 01). Conclusion Alpha2-adrenoceptor agonists can significantly decrease the incidence of emergence agitation in pediatric patients after sevoflurane anesthesia.
摘要:目的:定量測定50 %小兒在喉罩表面涂抹丁卡因膠漿的情況下平穩拔除喉罩時呼氣末七氟烷濃度。方法:25例擇期行四肢及體表手術的患兒,高流量吸入七氟烷誘導并以七氟烷和氧化亞氮維持麻醉,不使用肌肉松弛劑及靜脈麻醉藥物,手術結束后停止吸入氧化亞氮,并維持設定的七氟烷濃度10min后拔除喉罩。根據Dixon序貫法確定喉罩拔除時的七氟烷濃度,每0.1 Vol%七氟烷為1個增減單位。患兒未出現咳嗽、牙關緊閉、體動、屏氣及喉痙攣則認為拔除喉罩平穩。結果:50 %小兒平穩拔除喉罩時呼氣末七氟烷濃度(EC50)為1.22 Vol%(95 %的置信區間分別為0.99 Vol%～1.49 Vol%)。結論:在喉罩表面涂抹丁卡因膠漿的情況下,3～8歲患兒喉罩滿意拔除時呼氣末七氟烷EC50值為1.22 Vol%。Abstract: Objective: To determine the concentration of sevoflurane where 50%( EC50 ) of the attempts to remove the laryngeal mask airway (LMA ) with the Teracainum Gel would be successful in children. Methods: Twentyfive nonpremedicated children, aged 38 years old, ASA physical status I, scheduled for extremities or peripherical surgery were enrolled in this study. General anesthesia was induced with sevoflurane and maintained with sevoflurane and nitrous oxide in oxygen. After the surgery, the target concentration was maintained for at least 10 min, and then the LMA was removed. Each target concentration was predetermined by the Dixon’s upanddown method (with 0.1 Vol% as a step size), starting at 1.20 Vol% concentration of sevoflurane. A removal accomplished without coughing, teeth clenching, gross purposeful movement, breath holding or laryngospasm, during or within 1 min after removal was considered to be successful. Results:The concentration of sevoflurane to achieve successful LMA removal in 50% of children was 1.22 Vol% (95%CL, 0.99 Vol%1.49 Vol%). Conclusion: The EC50 value of sevoflurane for LMA smooth extubation in children aged 38 years old with teracainum gel was 1.22 Vol%.
